SA Breaking News Team (account@seekingalpha.com)
Post# of 30025
Posted On: 08/27/2014 10:05:06 PM
Re: MikeChavelle #4854
SA Breaking News Team (account@seekingalpha.com)
3:10 PM
Newsletters
Amarantus Q2 results • 4:10 PM
Douglas W. House, SA News Ed...
Amarantus Bioscience Holdings (OTCQB:AMBS +1.2%) Q2 results: Revenues: $0; Operating Expenses: $2.4M (+86.9%); Quick Assets: $2.4M.
No financial guidance given.
Read comments
AMBS price at time of publication: $0.12. Check AMBS price now »
Was this email forwarded to you? Learn more about Seeking Alpha Alerts here »
Focus Articles on AMBS
Why I'm Still Optimistic On LymPro And Amarantus Bio by Jason Napodano, CFA
Still Several Reasons To Remain Long Amarantus by Jason Napodano, CFA
New Cash To Help Drive Amarantus Pipeline by Jason Napodano, CFA
More News on AMBS
Amarantus calls warrants and converts debt Jul 9, 5:06 PM ET (Seeking Alpha)
Press Releases on AMBS
Amarantus Reports Second Quarter 2014 Financial Results, Announces Business Update Call (GlobeNewswire)
Amarantus to Present at Upcoming Investor Conferences (GlobeNewswire)
Amarantus Exercises Option to License Intellectual Property From University of Miami Bascom Palmer Eye Institute for Use of MANF in Retinal Disorders (GlobeNewswire)
Related Articles on AMBS
Behind The Promotion Of Northwest Bio by Richard Pearson
An Introduction To Neurotrophic Factors As Treatment For Neurodegenerative Diseases by Tal Ben-Ami
3 Approaches To Retinitis Pigmentosa by Andreas Spiro
StockTalk on AMBS: AMBS StockTalk | Twitter AMBS | Twitter $AMBS | AMBS Instablogs
Recent Market Alerts on AMBS: All news | Earnings | Dividends | M&A | On the move
Why are you receiving this? You subscribed to real-time News alerts at Seeking Alpha.
If this email was forwarded to you and you wish to receive this email directly, click here.
Manage your emails:
Get alerts on additional tickers and manage all your email alert choices here
I’m getting too many emails: manage your email alert choices
I’m no longer following AMBS: unsubscribe from all AMBS email alerts
This type of alert isn't helpful to me: unsubscribe from Breaking News alerts on AMBS
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Prices in this email are BATS Last Sale quotes.
Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017
3:10 PM
Newsletters
Amarantus Q2 results • 4:10 PM
Douglas W. House, SA News Ed...
Amarantus Bioscience Holdings (OTCQB:AMBS +1.2%) Q2 results: Revenues: $0; Operating Expenses: $2.4M (+86.9%); Quick Assets: $2.4M.
No financial guidance given.
Read comments
AMBS price at time of publication: $0.12. Check AMBS price now »
Was this email forwarded to you? Learn more about Seeking Alpha Alerts here »
Focus Articles on AMBS
Why I'm Still Optimistic On LymPro And Amarantus Bio by Jason Napodano, CFA
Still Several Reasons To Remain Long Amarantus by Jason Napodano, CFA
New Cash To Help Drive Amarantus Pipeline by Jason Napodano, CFA
More News on AMBS
Amarantus calls warrants and converts debt Jul 9, 5:06 PM ET (Seeking Alpha)
Press Releases on AMBS
Amarantus Reports Second Quarter 2014 Financial Results, Announces Business Update Call (GlobeNewswire)
Amarantus to Present at Upcoming Investor Conferences (GlobeNewswire)
Amarantus Exercises Option to License Intellectual Property From University of Miami Bascom Palmer Eye Institute for Use of MANF in Retinal Disorders (GlobeNewswire)
Related Articles on AMBS
Behind The Promotion Of Northwest Bio by Richard Pearson
An Introduction To Neurotrophic Factors As Treatment For Neurodegenerative Diseases by Tal Ben-Ami
3 Approaches To Retinitis Pigmentosa by Andreas Spiro
StockTalk on AMBS: AMBS StockTalk | Twitter AMBS | Twitter $AMBS | AMBS Instablogs
Recent Market Alerts on AMBS: All news | Earnings | Dividends | M&A | On the move
Why are you receiving this? You subscribed to real-time News alerts at Seeking Alpha.
If this email was forwarded to you and you wish to receive this email directly, click here.
Manage your emails:
Get alerts on additional tickers and manage all your email alert choices here
I’m getting too many emails: manage your email alert choices
I’m no longer following AMBS: unsubscribe from all AMBS email alerts
This type of alert isn't helpful to me: unsubscribe from Breaking News alerts on AMBS
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Prices in this email are BATS Last Sale quotes.
Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017
(0)
(0)